Belpointe Asset Management LLC Karuna Therapeutics, Inc. Transaction History
Belpointe Asset Management LLC
- $1.49 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding KRTX
# of Institutions
10Shares Held
332KCall Options Held
0Put Options Held
0-
Pictet Asset Management Sa Geneva 73, V8213KShares$00.06% of portfolio
-
Tekla Capital Management LLC58.6KShares$00.5% of portfolio
-
International Biotechnology Trust PLC London, X030.5KShares$01.75% of portfolio
-
Ea Series Trust Havertown, PA12.8KShares$00.1% of portfolio
-
Brinker Capital Investments, LLC6.1KShares$00.02% of portfolio
About Karuna Therapeutics, Inc.
- Ticker KRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,965,000
- Description
- Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...